John Hardy (geneticist)
John Anthony Hardy FRS (born 9 November 1954) is a human geneticist and molecular biologist whose research interests focus on neurological disease.
Career
Hardy received his B.Sc. (Hons) degree from the University of Leeds, UK (1976)[1] and three years later his Ph.D. from Imperial College, London, UK[1] where he studied dopamine and amino acid neuropharmacology. Dr. Hardy performed his postdoctoral training at the MRC Neuropathogenesis Unit in Newcastle upon Tyne, England and then further postdoctoral work at the Swedish Brain Bank in Umeå, Sweden where he started to work on Alzheimer's disease.[1]
He became Assistant Professor of Biochemistry at St. Mary's Hospital, Imperial College, London in 1985 and initiated genetic studies of Alzheimer's disease there.[2] He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the University of South Florida, in Tampa in 1992. In 1996 he moved to Mayo Clinic in Jacksonville, Florida, as Consultant and Professor of Neuroscience.
He became Chair of Neuroscience in 2000 and moved to National Institute of Ageing, Bethesda, Maryland, as Chief of the Laboratory of Neurogenetics in 2001. In 2007 he took up the Chair of Molecular Biology of Neurological Disease at the Reta Lila Weston Institute of Neurological Studies, University College London. He is currently the author of 317 articles,[2] with over 23,000 citations, the most cited Alzheimer's disease researcher in the UK (5th internationally).
Honours and Awards
He has won the MetLife, the Allied Signal and the Potamkin Prize for his work in describing the first genetic mutations, in the amyloid gene in Alzheimer's disease, in 1991. He was elected a Fellow of the Royal Society in 2009.
References
|